Literature DB >> 696312

Disseminated Herpes simplex virus infection in ataxia-telangiectasia.

A Ben-Zvi, D Soffer, S Yatziv.   

Abstract

The clinical and pathological features are described in a child with ataxia-telangiectasia, complicated by fatal disseminated herpes simplex virus infection. Herpes simplex virus was isolated from the patient's blood, and the histopathological findings in the skin, liver and adrenals were consistent with herpes simplex virus infection. The patient had a combined immune deficiency state, as a part of the ataxia-telangiectasia syndrome. She had imparied cellular immune response to herpes simplex virus and developed no antibodies against the virus. To our knowledge, this is the first fatal case of disseminated herpes simplex virus infection in ataxiatelangiectasia.

Entities:  

Mesh:

Year:  1978        PMID: 696312     DOI: 10.1111/j.1651-2227.1978.tb17821.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  B Cell-Specific Expression of Ataxia-Telangiectasia Mutated Protein Kinase Promotes Chronic Gammaherpesvirus Infection.

Authors:  Eric J Darrah; Joseph M Kulinski; Wadzanai P Mboko; Gang Xin; Laurent P Malherbe; Stephen B Gauld; Weiguo Cui; Vera L Tarakanova
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  ATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.

Authors:  Joseph M Kulinski; Eric J Darrah; Katarzyna A Broniowska; Wadzanai P Mboko; Bryan C Mounce; Laurent P Malherbe; John A Corbett; Stephen B Gauld; Vera L Tarakanova
Journal:  Virology       Date:  2015-05-21       Impact factor: 3.616

3.  ATM supports gammaherpesvirus replication by attenuating type I interferon pathway.

Authors:  Eric J Darrah; Kyle P Stoltz; Mitchell Ledwith; Vera L Tarakanova
Journal:  Virology       Date:  2017-07-18       Impact factor: 3.616

4.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.